On the stock market since 2004, it operates in the world of money and finance. It has 980 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 13% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
Buys outnumber sells, but taken together the trades don’t add up to a strong signal of confidence.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Executive Buying: The trades send no strong signal of confidence.
The stock trades 19% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 15% a year on average.
Sales run at $172.2M a year. A small number, but proof the product has real buyers.
It pays out $0.25 per share each year — regular cash for whoever holds the stock.
A loss of $5.9M against $172.2M in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
No clear buy-side message is coming from the executive floor. Council score: 3/10.
On our five-subject report card, HSONP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: HSONP is a high-risk stock — not yet profitable, and its future rides on its product catching on.